Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues

Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues

US Patent 9820995 · Granted Nov 21, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biodegradable intravitreal tyrosine kinase implants2021
4-pregenen-11β-17-21-triol-3,20-dione derivatives2019
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2019
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2019
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,22019
Biodegradable intravitreal tyrosine kinase implants2018
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,22017
4-pregenen-11β-17-21-triol-3,20-dione derivatives2016
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2016
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2016
Biodegradable intravitreal tyrosine kinase implants2016
Sustained release intraocular implants containing tyrosine kinase inhibitors and2015